Predictors of non-fatal myocardialinfarctions complications in patients with type 2 diabetes
Introduction. About a quarter of patients with myocardial infarction have type 2 diabetes mellitus, which signiﬁcantly worsens the prognosis in this group of patients.Aim of study was to assess the signiﬁcance of predictors of adverse outcomes of myocardial infarction in patients with type 2 diabetes mellitus due to development of hospital-acquired complications.Material and methods. The study included 107 diabetes patients with myocardial infarction including 61 patients (57.1%) with complicated non-fatal myocardial infarction, and 46 patients (42.9%) without complications. In addition to the clinical protocol for health examination and treatment, the modiﬁed Charlson comorbidity index, glycated hemoglobin level and high sensitivity C-reactive protein were evaluated for all patients discharged from the hospital.Results. Type 2 diabetes mellitus patients with non-fatal myocardial infarction had signiﬁcantly higher levels of modiﬁed Charlson comorbidity index, left ventricular dilatation and right atrial volume index as well as hyperglycemia and higher C-reactive protein levels, and the decrease in the left ventricular ejection fraction.Conclusions. In patients with type 2 diabetes mellitus, a higher incidence of non-fatal hospital-acquired complications of myocardial infarction is observed, the predictors of which are comorbidity, an active systemic inﬂammatory reaction, reduced contractility of the left ventricular myocardium, dilatation of the left ventricle and right atrium, and hyperglycemia at admission.